“ISOLATED V-LESIONS” DO NOT SHOW MOLECULAR REJECTION, BUT IN COMBINATION WITH MICROVASCULAR INFLAMMATION, INCREASE THE PROBABILITY OF MOLECULAR MIXED REJECTION

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

Presented the abstract " "
(Abstract co-author(s): )

Back

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.

E-Poster Format Requirements

PDF file
Layout: Portrait (vertical orientation)
One page only (Dim A4: 210 x 297mm or PPT)
E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
File Size: Maximum file size is 2 Megabytes (2 MB)
No hyperlinks, animated images, animations, and slide transitions
Language: English
Include your abstract number
E-posters can include QR codes, tables and photos

E-Poster

Abstract Title *

“ISOLATED V-LESIONS” DO NOT SHOW MOLECULAR REJECTION, BUT IN COMBINATION WITH MICROVASCULAR INFLAMMATION, INCREASE THE PROBABILITY OF MOLECULAR MIXED REJECTION

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

The title will not be accepted if it exceeds 25 words.
Type in CAPITAL LETTERS.
Lowercase may be used for abbreviations only, for example, mRNA.

Co-author 1

Evelyn Kowarik evelyn.kowarik@luks.ch University Hospital Zurich Nephrology Zurich Switzerland -

Co-author 2

Lukas Weidmann lukas.weidmann@usz.ch University Hospital Zurich Nephrology Zurich Switzerland -

Co-author 3

Dusan Harmacek dusan.harmacek@usz.ch University Hospital Zurich Nephrology Zurich Switzerland -

Co-author 4

Kai Castrezana-Lopez kai.castrezanalopez@usz.ch University Hospital Zurich Nephrology Zurich Switzerland -

Co-author 5

Elena Rho elena.rho@usz.ch University Hospital Zurich Nephrology Zurich Switzerland *

Co-author 6

Florian Westphal florian.westphal@usz.ch University Hospital Zurich Nephrology Zurich Switzerland -

Co-author 7

Kerstin Hübel kerstin.huebel@usz.ch University Hospital Zurich Nephrology Zurich Switzerland -

Co-author 8

Britta George britta.george@usz.ch University Hospital Zurich Nephrology Zurich Switzerland -

Co-author 9

Ariana Gaspert ariana.gaspert@usz.ch University Hospital Zurich Pathology Zurich Switzerland -

Co-author 10

Birgit Helmchen birgit.helmchen@usz.ch University Hospital Zurich Pathology Zurich Switzerland -

Co-author 11

Petra Hrubà hrup@ikem.cz Institute for Clinical and Experimental Medicine Nephrology Prague Czech Republic -

Co-author 12

Eva Girmanova eva.girmanova@ikem.cz Institute for Clinical and Experimental Medicine Nephrology Prague Czech Republic -

Co-author 13

Ondrej Viklicky ondrej.viklicky@ikem.cz Institute for Clinical and Experimental Medicine Nephrology Prague Czech Republic -

Co-author 14

Seraina von Moos seraina.vonmoos@luks.ch University Hospital Zurich Nephrology Zurich Czech Republic -

Co-author 15

Thomas Schachtner thomas.schachtner@usz.ch University Hospital Zurich Nephrology Zurich Czech Republic -